Tesaro downgraded to Neutral from Overweight at Cantor Fitzgerald. Cantor Fitzgerald analyst Young downgraded Tesaro (TSRO) to Neutral to reflect the takeover by GlaxoSmithKline (GSK). The analyst raised her price target for the shares to $75 from $68.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.